MALAT1 and non-small cell lung carcinoma: In another study, Zhong et al. [60] measured the five most predictive antibody markers, tentatively, paxillin, SEC15L2, BAC clone RP11-499F19, XRCC5, and MALAT1 in 23 stage 1 NSCLC patients and 23 risk-matched control samples.